First Time Loading...
A

Aurisco Pharmaceutical Co Ltd
SSE:605116

Watchlist Manager
Aurisco Pharmaceutical Co Ltd
SSE:605116
Watchlist
Price: 24.41 CNY -1.41% Market Closed
Updated: Apr 30, 2024

Aurisco Pharmaceutical Co Ltd
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Aurisco Pharmaceutical Co Ltd
Revenue Peer Comparison

Comparables:
C
1093
H
3692
600436
600276
000538

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
A
Aurisco Pharmaceutical Co Ltd
SSE:605116
Revenue
¥1B
CAGR 3-Years
20%
CAGR 5-Years
13%
CAGR 10-Years
N/A
C
CSPC Pharmaceutical Group Ltd
HKEX:1093
Revenue
¥31.5B
CAGR 3-Years
8%
CAGR 5-Years
12%
CAGR 10-Years
15%
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Revenue
¥10.1B
CAGR 3-Years
5%
CAGR 5-Years
6%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Revenue
¥9.7B
CAGR 3-Years
14%
CAGR 5-Years
16%
CAGR 10-Years
22%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Revenue
¥22.3B
CAGR 3-Years
-5%
CAGR 5-Years
7%
CAGR 10-Years
14%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Revenue
¥39.1B
CAGR 3-Years
6%
CAGR 5-Years
8%
CAGR 10-Years
9%

See Also

What is Aurisco Pharmaceutical Co Ltd's Revenue?
Revenue
1B CNY

Based on the financial report for Dec 31, 2022, Aurisco Pharmaceutical Co Ltd's Revenue amounts to 1B CNY.

What is Aurisco Pharmaceutical Co Ltd's Revenue growth rate?
Revenue CAGR 5Y
13%

Over the last year, the Revenue growth was 25%. The average annual Revenue growth rates for Aurisco Pharmaceutical Co Ltd have been 20% over the past three years , 13% over the past five years .